HEADLINES:  

The Indian pharma industry, which is expected to grow over 15 per cent per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same period. The market is expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size.

Branded generics dominate the pharmaceuticals market, constituting nearly 80 per cent of the market share. India has also maintained its lead over China in pharmaceutical exports with a year-on-year growth of 11.44 per cent to US$ 12.91 billion in FY 16.

In addition, Indian pharmaceutical exports are poised to grow between 8-10 per cent in FY 2016-17.


Imports of pharmaceutical products rose marginally by 0.80 per cent year-on-year to US$ 1,641.15 million.

Overall drug approvals given by the US Food and Drug Administration (USFDA) to Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-15.The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

  INDIAN PHARMACEUTICAL INDUSTRY AT A Glance IN 2015 - 2016

  INDIAN PHARMACEUTICAL INDUSTRY AT A Glance IN 2014 - 2015

  INDIAN PHARMACEUTICAL INDUSTRY AT A Glance IN 2013 - 2014

  INDIAN PHARMACEUTICAL INDUSTRY AT A Glance IN 2012 - 2013

  INDIAN PHARMACEUTICAL INDUSTRY AT A Glance IN 2011 - 2012

  Bulk Drug Manufacturers Association of INDIA

  back to pharmaceutical INDUSTRY